BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24060999)

  • 1. A proteomic approach of pediatric astrocytomas: MiRNAs and network insight.
    Ruiz Esparza-Garrido R; Velázquez-Flores MÁ; Diegopérez-Ramírez J; López-Aguilar E; Siordia-Reyes G; Hernández-Ortiz M; Martínez-Batallar AG; Encarnación-Guevara S; Salamanca-Gómez F; Arenas-Aranda DJ
    J Proteomics; 2013 Dec; 94():162-75. PubMed ID: 24060999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs as Biomarkers for Pediatric Astrocytomas.
    López-Aguilar JE; Velázquez-Flores MA; Simón-Martínez LA; Ávila-Miranda R; Rodríguez-Florido MA; Ruiz-Esparza Garrido R
    Arch Med Res; 2017 May; 48(4):323-332. PubMed ID: 29157673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductions in the expression of miR-124-3p, miR-128-1, and miR-221-3p in pediatric astrocytomas are related to high-grade supratentorial, and recurrent tumors in Mexican children.
    Eguía-Aguilar P; Pérezpeña-Díazconti M; Benadón-Darszon E; Chico-Ponce de León F; Gordillo-Domínguez L; Torres-García S; Sadowinski-Pine S; Arenas-Huertero F
    Childs Nerv Syst; 2014 Jul; 30(7):1173-81. PubMed ID: 24718706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2.
    Ho CY; Bar E; Giannini C; Marchionni L; Karajannis MA; Zagzag D; Gutmann DH; Eberhart CG; Rodriguez FJ
    Neuro Oncol; 2013 Jan; 15(1):69-82. PubMed ID: 23161775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentially Expressed Long Non-Coding RNAs Were Predicted to Be Involved in the Control of Signaling Pathways in Pediatric Astrocytoma.
    Ruiz Esparza-Garrido R; Rodríguez-Corona JM; López-Aguilar JE; Rodríguez-Florido MA; Velázquez-Wong AC; Viedma-Rodríguez R; Salamanca-Gómez F; Velázquez-Flores MÁ
    Mol Neurobiol; 2017 Oct; 54(8):6598-6608. PubMed ID: 27738870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
    Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
    Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor-b in human astrocytoma.
    Gollmer JC; Ladoux A; Gioanni J; Paquis P; Dubreuil A; Chatel M; Frelin C
    Neuro Oncol; 2000 Apr; 2(2):80-6. PubMed ID: 11303624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
    Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
    Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.
    Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
    Mol Neurobiol; 2017 Dec; 54(10):8162-8169. PubMed ID: 27900675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of MicroRNA expression in pediatric brain tumors.
    Birks DK; Barton VN; Donson AM; Handler MH; Vibhakar R; Foreman NK
    Pediatr Blood Cancer; 2011 Feb; 56(2):211-6. PubMed ID: 21157891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas.
    Braoudaki M; Lambrou GI; Giannikou K; Papadodima SA; Lykoudi A; Stefanaki K; Sfakianos G; Kolialexi A; Tzortzatou-Stathopoulou F; Tzetis M; Kitsiou-Tzeli S; Kanavakis E
    Tumour Biol; 2016 Jul; 37(7):9887-97. PubMed ID: 26813564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Bcl-2, Bcl-x, and Bax proteins in astrocytomas in relation to patient survival.
    Daido S; Tamiya T; Ono Y; Terada K; Mizumatsu S; Ohmoto T
    Brain Tumor Pathol; 2001; 18(2):123-9. PubMed ID: 11908868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
    Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated proteomic platforms for the comparative characterization of medulloblastoma and pilocytic astrocytoma pediatric brain tumors: a preliminary study.
    Martelli C; Iavarone F; D'Angelo L; Arba M; Vincenzoni F; Inserra I; Delfino D; Rossetti DV; Caretto M; Massimi L; Tamburrini G; Di Rocco C; Caldarelli M; Messana I; Castagnola M; Sanna MT; Desiderio C
    Mol Biosyst; 2015 Jun; 11(6):1668-83. PubMed ID: 25909245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms.
    Otero JJ; Rowitch D; Vandenberg S
    J Neurooncol; 2011 Sep; 104(2):423-38. PubMed ID: 21193945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas.
    Hirano H; Lopes MB; Laws ER; Asakura T; Goto M; Carpenter JE; Karns LR; VandenBerg SR
    Neuro Oncol; 1999 Apr; 1(2):109-19. PubMed ID: 11550306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
    Faria MH; Gonçalves BP; do Patrocínio RM; de Moraes-Filho MO; Rabenhorst SH
    Neuropathology; 2006 Dec; 26(6):519-27. PubMed ID: 17203587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas.
    Li D; Chen P; Li XY; Zhang LY; Xiong W; Zhou M; Xiao L; Zeng F; Li XL; Wu MH; Li GY
    OMICS; 2011 Oct; 15(10):673-82. PubMed ID: 21978395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression Profile of MiR-128 in the Astrocytoma Patients and Cell Lines.
    Xu J; Liu Y; Guo S; Ma S; Xiao L; Wei N; Xue R
    Mol Neurobiol; 2016 Sep; 53(7):4631-7. PubMed ID: 26307612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.